Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Consistent Intraocular Pressure Reduction by Solid Drug Nanoparticles in Fixed Combinations for Glaucoma Therapy

Advanced Science(2024)10.1002/advs.202401648Source: DataRank Database

Consistent Intraocular Pressure Reduction by Solid Drug Nanoparticles in Fixed Combinations for Glaucoma Therapy is a research paper published in Advanced Science (2024). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 6.23)OA: goldTopics (51)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Pedro Norat ORCID,Lin Qi,Anna Chernatynskaya ORCID,J. Dean Cole,Vimalin Jeyalatha Mani

Live enrichment

PubMed:38874068 PMC:PMC11336906 OpenAlex:https://openalex.org/W4399678299

National Institutes of Health

Grant: R01EY035088

National Institutes of Health

Grant: 7R01EY035088-04

Modulating aqueous humor outflow with engineered nanoparticles for glaucoma

Glaucoma Research Foundation Schaffer Grant, 4-VA Cavelier Collaborative Award.

FWCI

6.23

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/advs.202401648

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/advs.202401648

publisherhttps://advanced.onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202401648

journalhttps://doi.org/10.1002/advs.202401648

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38874068

Fields of Study

Glaucoma and retinal disordersOcular Surface and Contact LensCorneal Surgery and Treatments0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Brimonidine TartrateAnimalsAntihypertensive AgentsDisease Models, AnimalGlaucomaIntraocular PressureOphthalmic SolutionsBetaxololDrug Delivery SystemsMiceRatsNanoparticles

Keywords

BrimonidineGlaucomaDrug deliveryIn vivoBetaxololMaterials scienceTimololNanoparticleIntraocular pressureCorneaPharmacologyBiomedical engineeringNanotechnologyChemistryOphthalmologyMedicineocular hypertensionSolid Drug NanoparticlesScalable FabricationCornea PermeationAnti‐glaucoma DrugsScienceQRatsDisease Models, AnimalMiceDrug Delivery SystemsBrimonidine TartrateAnimalsNanoparticlesOphthalmic SolutionsAntihypertensive AgentsResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being